ANIX CEO Amit Kumar Buys Company Shares

Amit Kumar, CEO of ANIX, purchased 21,000 shares on June 12, 2026.

Key Points

  • ANIX CEO Amit Kumar bought 21,000 shares at $2.50 each on June 12, 2026, totaling $52,500.
  • ANIX shares currently trade around $2.48, with recent insider buying activity from both Kumar and other executives.
  • Analysts from D. Boral Capital and HC Wainwright & Co. maintain 'buy' ratings on ANIX, with price targets up to $10.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Amit Kumar, the CEO of ANIX, recently bought 21,000 shares of the company on June 12, 2026. He purchased the shares at an average price of $2.50 each, amounting to a total transaction value of $52,500. This purchase was not part of a pre-arranged trading plan.

Insider Buying and Selling at Anixa Biosciences, Inc.

Kumar's recent purchase adds to previous insider activity at ANIX. Earlier in the year, on January 5, 2026, Kumar acquired 350,000 shares. Other insiders, including Arnold Baskies and Emily Gottschalk, also made purchases on the same date. Baskies bought an additional 10,000 shares on January 28, 2026, at $3.04 per share.

Other Institutional Activity in ANIX

Several institutional investors have also been active in ANIX. Vanguard Capital Management LLC acquired 1,314,982 shares, now holding shares valued at approximately $3.39 million. Laird Norton Wetherby Trust Company, LLC reduced its position by 21,700 shares, ending with 566,327 shares worth about $1.46 million. UBS Group AG increased its holdings by 92,564 shares, bringing its total to 551,637 shares valued at roughly $1.42 million. Meanwhile, D.A. Davidson & Co. maintained its holdings at 539,272 shares, valued at approximately $1.39 million.

Anixa Biosciences, Inc. Stock Down 28.7%

ANIX shares are currently trading around $2.48. Despite recent insider buying, the stock remains volatile, attracting attention from both institutional investors and analysts. The company's financial metrics and market conditions continue to be closely monitored by stakeholders.

Year to date

$ANIX stock price

Daily closing prices, year to date. Not investment advice.

Analysts Set New Price Targets

Analysts have maintained a positive outlook on ANIX. On March 31, 2026, D. Boral Capital maintained its 'buy' rating with a price target of $10. Similarly, HC Wainwright & Co. reiterated its 'buy' rating with a $7 target on September 11, 2025. The consensus among analysts is a 'buy' rating, with a mean target price reflecting optimism about the company's future performance.

About ANIX

ANIX is a company engaged in developing innovative solutions across various sectors. With a focus on cutting-edge research and development, ANIX aims to deliver high-quality products and services to its customers. The company is led by CEO Amit Kumar and operates from its headquarters, striving to make significant contributions to its industry.

Bottom Line

Amit Kumar's recent purchase of ANIX shares underscores his confidence in the company's prospects. While insider buying is often seen as a positive signal, it's important to remember that these transactions do not guarantee future stock performance. Investors and analysts will continue to keep a close eye on ANIX's developments and market conditions.

Get Anixa Biosciences, Inc. alerts

New 13F filings, insider trades, and analyst moves on $ANIX, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.